MedPath

SmokefreeSGM Español Pilot, Beta Testing a Text-based Smoking Cessation Intervention for Sexual and Gender Minority(SGM) Groups Preferring Spanish Language

Not Applicable
Suspended
Conditions
Smoking Cessation
Interventions
Behavioral: SmokefreeSGM
Registration Number
NCT06487806
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

The purpose of this study is to test the usability, engagement and acceptability of SmokefreeSGM Español, a culturally and linguistically tailored version of SmokefreeSGM, among Spanish-speaking SGM smokers.

Detailed Description

Not available

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Currently live in the United States
  • Have smoked at least 100 cigarettes in their lifetime, smoke every day, and smoke ≥ 5 cigarettes a day
  • Are willing to quit smoking in the next 15 days
  • Have a cell phone number with an unlimited short message service (SMS) plan
  • Have a positive cotinine saliva test to indicate their smoking status
  • Speak fluent Spanish
Exclusion Criteria
  • Have a prepaid cell phone plan (pay-as-you-go plan)
  • Have a cell phone number that does not work and/or is registered to someone else
  • Have inadequate equipment/devices (i.e., webcam, speakers, mic) for participating in telehealth sessions via Microsoft Teams, Webex, or Zoom AND cannot meet in-person
  • Pregnant or breastfeeding persons (nicotine patches are not generally recommended to this groups since nicotine can affect fetal and neonatal brain development)
  • Contraindication for nicotine patches. Absolute contraindications include: severe eczema or serious skin conditions, allergy to nicotine patches, pregnancy, breastfeeding, heart attack in the past 2 months, ongoing angina, peptic ulcer disease, arrhythmia, or uncontrolled blood pressure. Potential contraindications include: stroke in the past 6 months, insulin therapy, and a current diagnosis of liver, kidney, or heart disease. Study participants reporting a potential contraindication will require approval from their primary care provider and/or other treating physician (e.g., psychiatrist) to use nicotine patches. If the request is denied or not returned in 2 weeks, potential study participants will be excluded from the study.
  • Current use of tobacco cessation medications
  • Current use of tobacco products other than cigarettes or electronic nicotine delivery systems (ENDS) (i.e., (e.g., cigar, cigarillo, little cigar, pipe, Hookah)
  • Enrollment in another smoking cessation study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Beta testing groupSmokefreeSGM-
Primary Outcome Measures
NameTimeMethod
Perceived Usability as Assessed by the System Usability Scale (SUS)end of intervention (1month after quit date)

This is a 10-item questionnaire. Total score ranges from 0 to 100, with a higher score indicating greater usability and a score above 75 indicating better outcome

Engagement with the text-messaging program as assessed by number of text messages a participant sends, including replies to the bidirectional texts messages of SmokefreeSGM Español programend of intervention (1month after quit date)
Acceptability at 1 month as Assessed by the System Usability Scale (SUS)end of intervention (1month after quit date)

This is a 10-item questionnaire. Total score ranges from 0 to 100, with a higher score indicating greater acceptability

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath